Clinical trial Recruiting at 1 site Interventional Ages 19 to 75

Comparing Sugammadex and Neostigmine for Muscle Relaxant Reversal After Lung Surgery

Official title: An Observational Study on the Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery

Run by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · NCT06334562 · Data updated 2026-11-12

This study is testing whether sugammadex or neostigmine works better to help patients recover from muscle relaxants after lung surgery.

More Neuromuscular Blockade trials

Quick facts

Study typeInterventional
Ages19 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
Academic / other
Locations1 site (Yiwu, Zhejiang)
StatusRecruiting
StartedJune 1, 2024
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 17, 2025
Trial IDNCT06334562 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old undergoing elective lung surgery requiring general anesthesia and endotracheal intubation.

Probably not a fit

Patients with severe comorbidities or contraindications to the study medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of sugammadex sodium and neostigmine in reversing neuromuscular blockade after thoracic surgery. Patients undergoing elective lung surgery under general anesthesia will receive either sugammadex or neostigmine after the administration of rocuronium bromide. The study will monitor recovery times of neuromuscular function and extubation, providing insights into optimizing muscle relaxant use during anesthesia. Data on dosage and recovery will be meticulously recorded to evaluate the outcomes of each reversal agent.

Why it matters

Potential benefit: If successful, this study could lead to improved recovery times and safety for patients undergoing thoracic surgery.

How similar studies have gone: Previous studies have shown promising results with sugammadex in reversing neuromuscular blockade, indicating that this approach is supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients who undergo elective lung surgery under general anesthesia and require endotracheal intubation;
2. Age\>18 years old, gender not limited;
3. American Society of Anesthesiologists ASA Level I-III;
4. Use rocuronium bromide for neuromuscular blockade;
5. The patient voluntarily participated in the trial.

Exclusion Criteria:

1. The patient explicitly refused to participate in this trial;
2. Family history of malignant hyperthermia, patients with allergies to sodium sulbactam, neostigmine ingredients and their excipients, and patients with allergies to drugs used during general anesthesia;
3. Patients with tracheal malformations or suspected difficult airways, coagulation dysfunction, severe liver and kidney dysfunction, and severe lung disease;
4. Patients who are not extubated and sent to the ward or ICU after surgery;
5. The researchers believe that patients with any other unfavorable factors to participate in this trial.

Where it's running

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine
    Yiwu, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: JianHong Xu — The Fourth Affiliated Hospital of Zhejiang University School of Medicine
  • Study coordinator: JianHong Xu
  • Email: xujh1969@163.com
  • Phone: 86-18867961109

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.